Clinical trials
Infection, Hospital clinical trials
Below are recruiting infection, hospital clinical trials, each written for real people, not researchers. We’re tracking 417 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07619924Enrolling by invitationEarly Phase 1
Phage Cocktail for Hard-to-Treat Skin Infections
This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.
Xi'an, ShaanxiAges 18–75 - NCT07725263Recruiting
Low-dose antifungal for kids with low white blood cells
This trial tests a low dose of an antifungal medicine (liposomal amphotericin B) to prevent serious fungal infections in children whose immune system is weak after cancer treatment or a stem cell transplant. It's for kids aged 3 to 17 who are at high risk for these infections.
Haikou, HainanAges 3–17 - NCT07672522Recruiting
Infections and the aging immune system in older adults
This study is looking at how infections and the aging immune system affect older adults. It compares people with an infection to healthy volunteers to understand how the body fights germs as we age.
Shanghai, Shanghai MunicipalityAges 60 years+ - NCT06880380RecruitingPhase 1
CAR-T cell therapy for functional HIV cure
This trial tests whether CAR-T cells can help control HIV without daily antivirals. It is for people with well-controlled HIV who want to explore a potential functional cure.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT07704164RecruitingPhase 2
Colchicine to lower heart artery swelling in HIV
This trial tests if colchicine, a medicine for inflammation, can reduce swelling in the heart arteries of people with HIV. It may help lower the risk of heart problems in those already on a statin or similar medication.
BarcelonaAges 50 years+ - NCT03097952Recruiting
Study of people with long-term hepatitis B in real life
This “real-life” study follows people with chronic hepatitis B to better understand their health over time. It may help researchers learn which factors affect outcomes in everyday care.
Changzhou, JiangsuAges Any age - NCT03449706Recruiting
Tracking immune changes in early HIV
This study looks closely at how your immune system and HIV infection markers change right after a new HIV diagnosis. It may help doctors understand the earliest stages of HIV and improve how infections are measured and followed over time.
Ghent, Oost-VlaanderenAges 18–65 - NCT04446676Recruiting
Stabilization method after staged knee revision for infection risk
This study compares two ways of stabilizing a knee implant after a two-step (staged) knee revision to see which better prevents reinfection. It may help people trying to avoid another infection after treatment of a previously infected knee implant.
Otwock, Masovian VoivodeshipAges 18–90 - NCT04970836Recruiting
Hepatitis B revaccination for young adults in Taiwan
This study looks at how well your immune system responds after getting 1–2 extra doses of the hepatitis B vaccine. It may help doctors understand who needs revaccination and how to strengthen protection.
TaipeiAges 20–36 - NCT05817825Recruiting
Remote program to support recovery after opioid use
This study tests a new intensive outpatient program delivered by video or phone to help people with opioid use disorder (and other substance use disorders) stay on track after leaving the hospital. It may help by offering structured support while you are at home.
Boston, MassachusettsAges 18 years+ - NCT05953233Recruiting
Air study in inner-city schools using home nasal swabs
This study looks at air in inner-city schools and how it may affect children’s health. You may be asked to collect nasal swab samples at home and answer questions, especially if your child’s classroom is part of the study.
Boston, MassachusettsAges 6–90 - NCT07345325RecruitingPhase 3
Comparing antibiotic treatments for heart valve infections
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
Aix-les-BainsAges 18 years+ - NCT07458984RecruitingPhase 3
Fecal transplant capsules for repeat C. diff infections
This trial tests if capsules containing fecal microbiota can prevent further Clostridioides difficile infections in people who have had at least two recurrences. If you've had multiple C. diff infections and your symptoms go away with antibiotics, this treatment might help keep them from coming back.
Helsinki, UusimaaAges 18 years+ - NCT07625176Enrolling by invitation
App-guided decisions for lung lining disease
This trial tests whether a decision-support app helps doctors better manage conditions affecting the pleura (the lining around your lungs)—like collapsed lung, fluid buildup, or infection. You'd be randomly assigned to use the app approach or standard care, and the study tracks how well each works.
AalborgAges 18 years+ - NCT07059819Enrolling by invitation
Local heat therapy for persistent high-risk HPV infection
This study tests whether local heat therapy can help clear a high-risk HPV infection that has lasted at least 3 months. It is for women who have no serious cervical cell changes or only mild changes (CIN) and who are generally healthy.
Shenyang, LiaoningAges 18–65 - NCT06467942Recruiting
Chinese medicine and probiotics for persistent HPV
This trial tests whether a combination of Chinese medicine and a probiotic (Lactobacillus) can help clear a long-lasting HPV infection. It's for women who have had the same high-risk HPV type for over a year and have not developed serious cervical changes.
Beijing, Beijing MunicipalityAges 25 years+ - NCT06572462RecruitingPhase 2
Individual ATG dosing for stem cell transplant from unrelated donors
This trial tests a personalized dosing method for a medicine called ATG, which helps prevent your body from rejecting a donor stem cell transplant. It is for people with blood cancers who need a transplant from an unrelated donor.
BeijingAges 14–65 - NCT06119256RecruitingPhase 1
TCR-T cells for EBV after stem cell transplant
This trial tests a new treatment using specially trained immune cells (TCR-T cells) to fight Epstein-Barr virus (EBV) infections that can occur after a stem cell transplant for blood cancer. It may help control the virus and prevent complications.
Beijing, Beijing MunicipalityAges 14–75 - NCT07501897Recruiting
Cold plasma for healing cannula wounds in ECLS patients
This trial tests whether cold atmospheric plasma—a gentle, gas-based treatment—can help heal wounds where tubes enter the body for life support. It might offer a new way to care for these delicate spots.
TaipeiAges 18 years+ - NCT05718726Recruiting
Study of infections after spleen removal surgery
This trial looks at what happens after surgery to remove the spleen in people who also have major cancer surgery through the belly. It may help reduce or better manage serious infections after this kind of operation.
Basingstoke, HampshireAges 18–79 - NCT04679584Recruiting
Study of long-term effects after COVID-19 infection
This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.
Würzburg, BavariaAges 18 years+ - NCT07453966Recruiting
Lung vibration therapy for people on breathing machines with lung infection
This study tests a device that delivers gentle vibrations to the lungs to help clear infection in people who are on a breathing machine. It may help improve oxygen levels and recovery.
Wuhan, HubeiAges 18 years+ - NCT05775614Enrolling by invitation
Catheter care rinse study to prevent infections and improve comfort
This study tests a catheter “rinse” product (UroTainer) or plain saline to help keep a permanent catheter working and reduce infection risk. It also looks at comfort and quality of life for people who have had catheter problems like blockage or buildup.
OdenseAges 18 years+ - NCT05387005Recruiting
Check who should be tested for H. pylori to prevent stomach cancer
This study looks at a screening plan to prevent stomach cancer by identifying people who should be tested and treated for H. pylori, a common stomach germ. If you have never had H. pylori testing or treatment, the trial may help determine the best approach for prevention.
TaipeiAges 20 years+
Hear when a new Infection, Hospital trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infection, hospital?
- Yes. Clin2 currently lists 417 recruiting infection, hospital studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infection, hospital trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infection, hospital trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.